SCHEMBL9813136

SCHEMBL9813136

CCCC12CCC(=O)C=C1c1c(cc(OCC(=N)N)c(Cl)c1Cl)C2

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 10/20 0.48
ESR1 P03372 7/20 0.48
HSD17B10 Q99714 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
LMNA P02545 2/20 0.39
BLM P54132 2/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39
GMNN O75496 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TSHR P16473 2/20 0.37
HIF1A Q16665 1/20 0.37
ALOX15 P16050 1/20 0.36
RECQL P46063 1/20 0.36
GRM2 Q14416 5/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9813279 0.99 ESR2 (0.48) ESR2ESR1HSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL9815629 0.98 ESR2 (0.47) ESR2ESR1HSD17B10MEN1KMT2A
SCHEMBL9813141 0.93 ESR2 (0.47) ESR2ESR1HSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL10627514 0.92 ESR2 (0.41) ESR2ESR1HSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL9815617 0.92 ESR2 (0.47) ESR2ESR1HSD17B10MEN1KMT2A
SCHEMBL7983269 0.91 ESR2 (0.49) ESR2ESR1HSD17B10MEN1KMT2A
SCHEMBL10660467 0.91 ESR2 (0.38) ESR2ESR1HSD17B10MEN1KMT2A
SCHEMBL9813270 0.91 ESR2 (0.47) ESR2ESR1HSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL10655569 0.90 ESR2 (0.37) ESR2ESR1HSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL9815730 0.90 ESR2 (0.46) ESR2ESR1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0217287-B1 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)-oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts MERCK & CO. INC. (US) 1991-06-26 EP claimed
EP-0217287-A2 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)-oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts MERCK & CO. INC. (US) 1987-04-08 EP claimed
EP-0217287-B1 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)-oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts MERCK & CO. INC. (US) 1991-06-26 EP disclosed
EP-0217287-A2 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)-oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts MERCK & CO. INC. (US) 1987-04-08 EP disclosed
US-4604396-A TREATMENT OF GREY MATTER EDEMAS MERCK & CO., INC. (US) 1986-08-05 US disclosed